Antibody responses to Brugia malayi antigens induced by DNA vaccination

Filaria Journal

Volumn 3, Issue , 2004, Pages

  Li, Ben Wen ^a   Rush, Amy R ^a   Zhang, Shaorong R Z ^a   Curtis, Kurt C C ^a   Weil, Gary J W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERMEDIATE FILAMENT PROTEIN; PARAMYOSIN; PARASITE ANTIBODY; PARASITE ANTIGEN; PLASMID DNA; RECOMBINANT ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BRUGIA MALAYI; CONTROLLED STUDY; DRUG MIXTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EUKARYOTE; EXPRESSION VECTOR; FILARIA; GENE GUN; GENE INSERTION; GENETIC CODE; IMMUNE RESPONSE; IMMUNIZATION; INOCULATION; KRUSKAL WALLIS TEST; MOUSE; MOUSE STRAIN; NEMATODE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE; PLASMID; RECOMBINANT PLASMID; SERODIAGNOSIS; STATISTICAL PARAMETERS; STATISTICAL SIGNIFICANCE; TH1 CELL; TH2 CELL; VACCINATION;

EID: 2942605891     PISSN: 14752883     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2883-3-1     Document Type: Article

References (29)

1. Ottesen EA, Duke BO, Karam M, Behbehani K: Strategies and tools for the control/elimination of lymphatic filariasis. Bull WHO 1997, 75:491-503.
2. 60cobaltattenuated infective stage larvae protects jird against homologous challenge. Am J Trop med Hyg 1985, 34:1132-37.
3. Weil G, Li BW, Liftis F, Chandrashekar R: Brugia malayi: Antibody responses to larval antigens in infected and immunized jirds. Exp Parasitol 1992, 74:315-23.
4. Montgomery DL, Ulmer JB, Donnelly JJ, Liu MA: DNA Vaccines. Pharmacol Ther 1997, 74:195-205.
5. Li BW, Chandrashekar R, Weil G: Vaccination with recombinant filarial paramyosin induces partial immunity to Brugia malayi infection in jirds. J Immunol 1993, 150:1881-85.
6. Li BW, Zhang SR, Curtis KC, Weil G: Immune responses to Brugia malayi paramyosin in rodents after DNA vaccination. Vaccine 1999, 18:76-81.
7. Leitner W, Yang H, Restifo NP: DNA and RNA based vaccines: principles, progress and prospects. Vaccine 2000, 18:765-77.
8. Robinson HL: Nucleic acid vaccines: an overview. Vaccine 1997, 15:785-87.
9. Pertmer TM, Roberts TR, Haynes JR: Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses solicited by DNA vaccination are dependent on the route of vector DNA delivery. J Virol 1996, 70:6119-25.
10. Wolf JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL: Direct gene transfer into mouse muscle in vivo. Science 1990, 347:1465-68.
11. Robinson HL: DNA vaccines: basic mechanism and immune responses [Review]. Int J Mol Med 1999, 4:549-55.
12. Eisenbraun MD, Fuller DH, Haynes JR: Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA Cell Biol 1993, 12:791-97.
13. Tang DC, De Vit M, Johnston SA: Genetic immunization is a simple method for eliciting an immune response. Nature 1992, 356:152-54.
14. McCluskie MJ, Millan CLB, Gramzinki RA, Robinson HL, Santoro JC, Fuller JT, Widera G, Haynes JR, Purcell RH, Davis HL: Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates. Mol Med 1999, 5:287-300.
15. Boyle J, Silva A, Brady JL, Lew A: DNA immunization: Induction of higher avidity antibody and effect of route on T cell cytotoxicity. Proc Natl Acad Sci USA 1997, 94:1426-31.
16. Li BW, Chandrashekar R, Alvarez R, Liftis F, Weil GJ: Identification of paramyosin as a potential protective antigen against Brugia malayi infection in jirds. Mol Biochem Parasitol 1991, 49:315-24.
17. Chandrashekar R, Curtis KC, Ramzy RM, Liftis F, Li BW, Weil GJ: Molecular cloning of Brugia malayi antigens for diagnosis of lymphatic filariasis. Mol Biochem Parasitol 1994, 64:261-71.
18. Chandrashekar R, Curtis KC, Li BW, Weil GJ: Molecular characterization of Brugia malayi intermediate filament protein which is an excretory product of adult worms. Mol Biochem Parasitol 1995, 73:231-39.
19. Coffman RL, Seymour BWP, Leibman DA: The role of helper T cell products in mouse B differentiation and isotype regulation. Immunol Reviews 1988, 102:5-28.
20. Donnelly JJ, Ulmer JB, Shiver JW, Liu MA: DNA vaccines. Annu Rev Immunol 1997, 15:617-48.
21. Davis HL, McCluskie JM: DNA vaccines for viral diseases. Microb Infect 1999, 1:7-23.
22. Feltquate DM, Heaney S, Webster RG, Robinson HL: Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 1997, 158:2278-84.
23. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL: DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA 1993, 90:11478-82.
24. Wolff JA, Williams P, Acsadi G, Jiao S, Jani A, Chong W: Conditions affecting direct gene transfer into rodent muscle in vivo. Biotechniques 1991, 11:474-85.
25. Raz E, Carson DA, Parker SE, Parr TB, Abai AM, Aichinger G, Gromkowski SH, Singh M, Lew D, Yankauckas MA: Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci USA 1994, 91:9519-23.
26. Cardoso AI, Sixt N, Vallier A, Fayolle J, Buckland R, Wild TF: Measles virus DNA vaccination: Antibody isotype is determined by the method of immunization and the nature of both the antigen and the coimmunized antigen. J Virol 1998, 72:2516-18.
27. Hoffman SL, Doolan DL, Sedegah M, Gramzinski R, Wang H, Gowda K, Hobart P, Margalith P, Norman J, Hedstrom RC: Nucleic acid malaria vaccines. Current status and potential. Ann N Y Acad Sci 1995, 772:88-94.
28. Leitner WW, Seguin MC, Ballou WR, Seitz JP, Schultz AM, Sheehy MJ, Lyon JA: Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites. J Immunol 1997, 159:6112-19.
29. Davis HL, Mancini M, Michel ML, Whalen RG: DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. Vaccine 1996, 14:910-15.